BioSpace News Archive

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company with marketed products and a pipeline of development candidates, announced that Seth Lederman, M.D., Chief Executive Officer, will present at The 6th International Congress on Controversies in Fibromyalgia in Brussels, Belgium on March 7, 2024.

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced that it will host a live webcast at 8:30 am ET on Thursday, March 7, 2024, to report its fourth quarter and full year 2023 financial results and provide recent business progress.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at TD Cowen’s 44th Annual Health Care Conference on March 6, 2024.

ClearPoint Neuro, Inc., a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announced the pricing of its underwritten public offering of 2,307,694 shares of its common stock at a price to the public of $6.50 per share.

EndoSound™ Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024.

Destroy Duchenne, a nonprofit organization founded by DMD patient, Elijah Stacy that aims to Complete the CureTM for Duchenne Muscular Dystrophy (DMD), and DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, today announced a partnership to develop new targeted non-viral gene therapy technologies for DMD.

SpringWorks Therapeutics, Inc. announced today that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for nirogacestat, an oral gamma secretase inhibitor, for the treatment of adults with desmoid tumors.

Perimeter Medical Imaging AI, Inc. announced results from a peer-reviewed retrospective study 1 examining the integration of Wide Field Optical Coherence Tomography (WF-OCT) with Perimeter’s proprietary and investigational “ImgAssist” artificial intelligence technology, an AI-driven clinical decision support system created to enhance productivity and decision making in breast cancer surgery margin assessment.

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) today announced that David O’Toole, Chief Financial Officer, will present at TD Cowen’s 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:50 a.m. Eastern Time.

Celanese Announces Commercial Launch of Glaukos’ iDose ® TR (Travoprost Intracameral Implant) Using Celanese’s VitalDose ® Ethylene Vinyl Acetate (EVA).